Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.

G protein-coupled receptors (GPCRs) play crucial roles in cell physiology and pathophysiology. There is increasing interest in using structural information for virtual screening (VS) of libraries and for structure-based drug design to identify novel agonist or antagonist leads. However, the sparse a...

Full description

Bibliographic Details
Main Authors: Thomas Coudrat, John Simms, Arthur Christopoulos, Denise Wootten, Patrick M Sexton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-11-01
Series:PLoS Computational Biology
Online Access:http://europepmc.org/articles/PMC5708846?pdf=render
_version_ 1819101023813238784
author Thomas Coudrat
John Simms
Arthur Christopoulos
Denise Wootten
Patrick M Sexton
author_facet Thomas Coudrat
John Simms
Arthur Christopoulos
Denise Wootten
Patrick M Sexton
author_sort Thomas Coudrat
collection DOAJ
description G protein-coupled receptors (GPCRs) play crucial roles in cell physiology and pathophysiology. There is increasing interest in using structural information for virtual screening (VS) of libraries and for structure-based drug design to identify novel agonist or antagonist leads. However, the sparse availability of experimentally determined GPCR/ligand complex structures with diverse ligands impedes the application of structure-based drug design (SBDD) programs directed to identifying new molecules with a select pharmacology. In this study, we apply ligand-directed modeling (LDM) to available GPCR X-ray structures to improve VS performance and selectivity towards molecules of specific pharmacological profile. The described method refines a GPCR binding pocket conformation using a single known ligand for that GPCR. The LDM method is a computationally efficient, iterative workflow consisting of protein sampling and ligand docking. We developed an extensive benchmark comparing LDM-refined binding pockets to GPCR X-ray crystal structures across seven different GPCRs bound to a range of ligands of different chemotypes and pharmacological profiles. LDM-refined models showed improvement in VS performance over origin X-ray crystal structures in 21 out of 24 cases. In all cases, the LDM-refined models had superior performance in enriching for the chemotype of the refinement ligand. This likely contributes to the LDM success in all cases of inhibitor-bound to agonist-bound binding pocket refinement, a key task for GPCR SBDD programs. Indeed, agonist ligands are required for a plethora of GPCRs for therapeutic intervention, however GPCR X-ray structures are mostly restricted to their inactive inhibitor-bound state.
first_indexed 2024-12-22T01:12:05Z
format Article
id doaj.art-4e7ed5d171f84e11b0c5527b7366249d
institution Directory Open Access Journal
issn 1553-734X
1553-7358
language English
last_indexed 2024-12-22T01:12:05Z
publishDate 2017-11-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Computational Biology
spelling doaj.art-4e7ed5d171f84e11b0c5527b7366249d2022-12-21T18:43:56ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582017-11-011311e100581910.1371/journal.pcbi.1005819Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.Thomas CoudratJohn SimmsArthur ChristopoulosDenise WoottenPatrick M SextonG protein-coupled receptors (GPCRs) play crucial roles in cell physiology and pathophysiology. There is increasing interest in using structural information for virtual screening (VS) of libraries and for structure-based drug design to identify novel agonist or antagonist leads. However, the sparse availability of experimentally determined GPCR/ligand complex structures with diverse ligands impedes the application of structure-based drug design (SBDD) programs directed to identifying new molecules with a select pharmacology. In this study, we apply ligand-directed modeling (LDM) to available GPCR X-ray structures to improve VS performance and selectivity towards molecules of specific pharmacological profile. The described method refines a GPCR binding pocket conformation using a single known ligand for that GPCR. The LDM method is a computationally efficient, iterative workflow consisting of protein sampling and ligand docking. We developed an extensive benchmark comparing LDM-refined binding pockets to GPCR X-ray crystal structures across seven different GPCRs bound to a range of ligands of different chemotypes and pharmacological profiles. LDM-refined models showed improvement in VS performance over origin X-ray crystal structures in 21 out of 24 cases. In all cases, the LDM-refined models had superior performance in enriching for the chemotype of the refinement ligand. This likely contributes to the LDM success in all cases of inhibitor-bound to agonist-bound binding pocket refinement, a key task for GPCR SBDD programs. Indeed, agonist ligands are required for a plethora of GPCRs for therapeutic intervention, however GPCR X-ray structures are mostly restricted to their inactive inhibitor-bound state.http://europepmc.org/articles/PMC5708846?pdf=render
spellingShingle Thomas Coudrat
John Simms
Arthur Christopoulos
Denise Wootten
Patrick M Sexton
Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
PLoS Computational Biology
title Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
title_full Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
title_fullStr Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
title_full_unstemmed Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
title_short Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
title_sort improving virtual screening of g protein coupled receptors via ligand directed modeling
url http://europepmc.org/articles/PMC5708846?pdf=render
work_keys_str_mv AT thomascoudrat improvingvirtualscreeningofgproteincoupledreceptorsvialiganddirectedmodeling
AT johnsimms improvingvirtualscreeningofgproteincoupledreceptorsvialiganddirectedmodeling
AT arthurchristopoulos improvingvirtualscreeningofgproteincoupledreceptorsvialiganddirectedmodeling
AT denisewootten improvingvirtualscreeningofgproteincoupledreceptorsvialiganddirectedmodeling
AT patrickmsexton improvingvirtualscreeningofgproteincoupledreceptorsvialiganddirectedmodeling